Anthony Loke - Photo DAP
KUALA LUMPUR — Transport Minister Anthony Loke has urged motorists nationwide to settle their outstanding Road Transport Department (JPJ) summonses before the ongoing 50% discount offer ends on December 30.
As of now, more than 5.5 million JPJ summonses remain unpaid, with 1.3 million issued under the Automated Awareness Safety System (AWAS) and 3.68 million under JPJP. Loke warned that beginning January 1, 2026, failure to clear outstanding summonses could result in court action and blacklisting of vehicle and driving licences.
He explained that starting next year, there will be no more blanket discounts. Instead, a structured compound rate will apply. Offenders who settle their summonses within 15 days will pay 50% of the compounded amount, while those who delay payment beyond 30 days must pay the full amount.
“Both PDMM and JPJ have provided a grace period for the public to settle all outstanding summonses and compounds,” Loke said. “This two-month period from November 1 to December 30 is your final opportunity to enjoy the 50% discount.”
Loke emphasized that the initiative aims to encourage compliance while promoting safer and more disciplined road use.
“Let us work together to ensure more efficient enforcement for the safety and order of our roads,” he said, urging all road users to act promptly before the year-end deadline.
Read More News on Latest Malaysia
Read More News on Business News Malaysia
Read More News on SG Business News
Read More News on World Future TV
GDEX posts weak 1QFY26 results, but restructuring and GD Xchange growth support long‑term outlook; BUY…
Kerjaya Prospek Group Bhd’s net profit in 1QFY26 increased by 24.5%, boosted by construction division…
FBM KLCI rebounds on tech gains, tracking global optimism, though geopolitical risks and oil prices…
The government has disbursed RM4bil under its RM15bil PowerUp 10K financing initiative, benefiting over 150,000…
More Malaysian women in finance are pursuing entrepreneurship, strengthening SME growth, innovation, leadership diversity, and…
Partnership integrates Sandoz biosimilars into Alpro Pharmacy’s OncoHelp programme to support patients from government hospitals…
This website uses cookies.